Silencing of immunoglobulin superfamily containing leucine-rich repeat inhibits gastric cancer cell growth and metastasis by regulating epithelial–mesenchymal transition

References

• Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635–648.
   PubMed Web of Science ®Google Scholar
• Petryszyn P, Chapelle N, Matysiak-Budnik T. Gastric cancer: where are we heading? Dig Dis. 2020;38(4):280–285.
   PubMed Web of Science ®Google Scholar
• Bure IV, Nemtsova MV, Zaletaev DV. Roles of E-cadherin and noncoding RNAs in the epithelial-mesenchymal transition and progression in gastric cancer. Int J Mol Sci. 2019;20(12):2870.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang M, Hu X, et al. miRNA-194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1. FEBS Open Bio. 2021;11(7):1814–1826.
   PubMed Web of Science ®Google Scholar
• Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38.
   PubMed Web of Science ®Google Scholar
• Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep. 2019;21(8):67.
   PubMed Web of Science ®Google Scholar
• Camargo MC, Figueiredo C, Machado JC. Review: gastric malignancies: basic aspects. Helicobacter. 2019;24(S1):e12642.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Oda I, Abe S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19(1):198–205.
   PubMed Web of Science ®Google Scholar
• Li D, Cheng P, Wang J, et al. IRF6 is directly regulated by ZEB1 and ELF3, and predicts a favorable prognosis in gastric cancer. Front Oncol. 2019;9:220.
   PubMed Web of Science ®Google Scholar
• Nagasawa A, Kudoh J, Noda S, et al. Human and mouse ISLR (immunoglobulin superfamily containing leucine-rich repeat) genes: genomic structure and tissue expression. Genomics. 1999;61(1):37–43.
   PubMed Web of Science ®Google Scholar
• Nagasawa A, Kubota R, Imamura Y, et al. Cloning of the cDNA for a new member of the immunoglobulin superfamily (ISLR) containing leucine-rich repeat (LRR). Genomics. 1997;44(3):273–279.
   PubMed Web of Science ®Google Scholar
• Lind L, Sandstrom H, Wahlin A, et al. Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. Hum Mol Genet. 1995;4(1):109–112.
   PubMed Web of Science ®Google Scholar
• Homma S, Shimada T, Hikake T, et al. Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene Expression Patterns GEP. 2009;9(1):1–26.
   PubMed Web of Science ®Google Scholar
• Yoon IK, Kim HK, Kim YK, et al. Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology. Exp Gerontol. 2004;39(9):1369–1378.
   PubMed Web of Science ®Google Scholar
• Lugowska A, Hetmanczyk-Sawicka K, Iwanicka-Nowicka R, et al. Gene expression profile in patients with gaucher disease indicates activation of inflammatory processes. Sci Rep. 2019;9(1):6060.
   PubMed Web of Science ®Google Scholar
• Li S, Zhao W, Sun M. An analysis regarding the association between the ISLR gene and gastric carcinogenesis. Front Genet. 2020;11:620.
   PubMed Web of Science ®Google Scholar
• Yue B, Song C, Yang L, et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer. 2019;18(1):142.
   PubMed Web of Science ®Google Scholar
• Huang X, Chen C, Xu Y, et al. Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer. Bioengineered. 2021;12(1):2688–2701.
   PubMed Web of Science ®Google Scholar
• Cui X, Shan T, Qiao L. Collagen type IV alpha 1 (COL4A1) silence hampers the invasion, migration and epithelial–mesenchymal transition (EMT) of gastric cancer cells through blocking Hedgehog signaling pathway. Bioengineered. 2022;13(4):8972–8981.
   PubMed Web of Science ®Google Scholar
• Wang X, Li Y, Fang Z, et al. Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation. Bioengineered. 2021;12(2):12204–12214.
   PubMed Web of Science ®Google Scholar
• Dalby B, Cates S, Harris A, et al. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods. 2004;33(2):95–103.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Yang J, Fan L, Liao X, et al. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway. Bioengineered. 2021;12(2):9377–9389.
   PubMed Web of Science ®Google Scholar
• Zhao N, Wang C, Guo P, et al. CCDC106 promotes the proliferation and invasion of ovarian cancer cells by suppressing p21 transcription through a p53-independent pathway. Bioengineered. 2022;13(4):10957–10973.
   PubMed Web of Science ®Google Scholar
• Yu Y, Wang W, Lu W, et al. Inhibin β-A (INHBA) induces epithelial-mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-β signaling pathway. Bioengineered. 2021;12(1):4681–4696.
   PubMed Web of Science ®Google Scholar
• Zhong X, Cai Y. Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway. Bioengineered. 2021;12(2):9113–9127.
   PubMed Web of Science ®Google Scholar
• Wang J-S, Wang M-J, Lu X, et al. Artesunate inhibits epithelial-mesenchymal transition in non-small-cell lung cancer (NSCLC) cells by down-regulating the expression of BTBD7. Bioengineered. 2020;11(1):1197–1207.
   PubMed Web of Science ®Google Scholar
• Therneau TM, Lumley T. Package ‘survival’. R Top Doc. 2015;128:28–33.
   Google Scholar
• Aea S. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• Wu CE, Xue WW, Zhuang YW, et al. A clinical study on the efficacy of Yiqi Huayu Jiedu decoction for reducing the risk of postoperative recurrence and metastasis of gastric cancer: protocol for a multicenter, randomized, double-blind, placebo-controlled trial. Medicine (Baltimore). 2020;99(48):e23417.
   PubMed Web of Science ®Google Scholar
• Sandoval-Borquez A, Saavedra K, Carrasco-Avino G, et al. Noncoding genomics in gastric cancer and the gastric precancerous cascade: pathogenesis and biomarkers. Dis Markers. 2015;2015:503762.
   PubMed Web of Science ®Google Scholar
• Jia ZF, Zhang SL, Cao XY, et al. Interaction between Helicobacter pylori and host genetic variants in gastric carcinogenesis. Future Oncol. 2016;12(18):2127–2134.
   PubMed Web of Science ®Google Scholar
• Tanikawa C, Kamatani Y, Toyoshima O, et al. Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21. Cancer Sci. 2018;109(12):4015–4024.
   PubMed Web of Science ®Google Scholar
• Cui C, Han S, Shen X, et al. ISLR regulates skeletal muscle atrophy via IGF1-PI3K/Akt-Foxo signaling pathway. Cell Tissue Res. 2020;381(3):479–492.
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhang Y, Gu L, et al. Islr regulates canonical Wnt signaling-mediated skeletal muscle regeneration by stabilizing dishevelled-2 and preventing autophagy. Nat Commun. 2018;9(1):5129.
   PubMed Web of Science ®Google Scholar
• Xu J, Tang Y, Sheng X, et al. Secreted stromal protein ISLR promotes intestinal regeneration by suppressing epithelial Hippo signaling. EMBO J. 2020;39(7):e103255.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Gieniec KA, Wright JA, et al. The balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis. Gastroenterology. 2020;160(4): 1224–1239.
   PubMed Web of Science ®Google Scholar
• Choi RS, Lai WYX, Lee LTC, et al. Current and future molecular diagnostics of gastric cancer. Expert Rev Mol Diagn. 2019;19(10):863–874.
   PubMed Web of Science ®Google Scholar
• Tam C, Wong JH, Tsui SKW, et al. LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years. Appl Microbiol Biotechnol. 2019;103(12):4649–4677.
   PubMed Web of Science ®Google Scholar
• Li D, Wang J, Zhang M, et al. LncRNA MAGI2-AS3, regulated by BRD4, is an independent prognostic marker and promotes gastric cancer progression via maintaining ZEB1 overexpression. Mol Ther Nucleic Acids. 2019;19:109–123.
   PubMedGoogle Scholar
• Li D, She J, Hu X, et al. The ELF3-regulated lncRNA UBE2CP3 is over-stabilized by RNA–RNA interactions and drives gastric cancer metastasis via miR-138-5p/ITGA2 axis. Oncogene. 2021;40(35):1–13.
   PubMed Web of Science ®Google Scholar
• Li D, Xu M, Wang Z, et al. The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p/VAMP7 axis. Cell Death Dis. 2022;13(1): 022–04540.
   Web of Science ®Google Scholar
• Li G, Su Q, Liu H, et al. Frizzled7 promotes epithelial-to-mesenchymal transition and stemness via activating canonical Wnt/beta-catenin pathway in gastric cancer. Int J Biol Sci. 2018;14(3):280–293.
   PubMed Web of Science ®Google Scholar
• Xu G, Meng L, Yuan D, et al. MEG3/miR21 axis affects cell mobility by suppressing epithelial mesenchymal transition in gastric cancer. Oncol Rep. 2018;40(1):39–48.
   PubMed Web of Science ®Google Scholar
• Fioroni I, Dell’Aquila E, Pantano F, et al. Role of c-mesenchymal-epithelial transition pathway in gastric cancer. Expert Opin Pharmacother. 2015;16(8):1195–1207.
   PubMed Web of Science ®Google Scholar
• Hu L, Zang MD, Wang HX, et al. Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway. Mol Oncol. 2016;10(9):1473–1484.
   PubMed Web of Science ®Google Scholar
• Busuttil RA, George J, House CM, et al. SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence. Gastric Cancer. 2020;24(3):589–601.
   PubMed Web of Science ®Google Scholar